CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Safe Environment
(Tag F0584)
Could have caused harm · This affected 1 resident
Based on observation, interview, record review and review of other pertinent documentation, it was determined that the facility failed to maintain a residents wheelchair and cushion in a clean and hom...
Read full inspector narrative →
Based on observation, interview, record review and review of other pertinent documentation, it was determined that the facility failed to maintain a residents wheelchair and cushion in a clean and homelike manner. This deficient practice was identified for 1 of 3 residents reviewed for care of equipment and maintenance, Resident #63 and was evidenced by the following:
The surveyor toured the 400's Unit on 2/11/2022 at 11:30 AM and observed Resident #63 siting on the bed, he/she did not acknowledged the surveyor when the surveyor entered the room. Next to the bed the surveyor observed a ripped and torn wheelchair, the cushion was torn in several places exposing the yellow foam. Some particles and food like debris were noted on the torn cushion.
On 2/14/2022 at 11:45 AM, the surveyor observed Resident #63 sitting in the room, the wheelchair was noted at the bedside, ripped and torn in different places. The cushion was ripped and also torn in different areas.
The surveyor reviewed Resident #63's medical record on 2/26/2022. The admission Face Sheet revealed that Resident #63 was admitted to the facility with diagnoses which included but not limited to Alzheimer's Disease, Depression and Schizophrenia, acquired absence of right leg below knee, and acquired absence of left leg below knee.
A review of the Quarterly Minimum Data Set (MDS) an assessment tool used to prioritize care, dated 11/18/21, coded Resident #63 as being severely cognitively impaired with a score of 03 out of 15 on the Brief Interview for Mental Status (BIMS).
On 2/15/22 at 11:05 AM, an interview with the Unit Manager Registered Nurse (UM/RN) revealed that housekeeping power washed the wheelchairs every Monday but she was not aware that the wheelchair needed to be repaired.
On 2/15/22 at 11:19 AM, the surveyor interviewed the Physical Therapy (PT) Director regarding Resident #63's wheelchair's condition. He stated that he was not aware of the wheelchair condition. He stated that he attended daily morning meeting and was never informed of the wheelchair condition. The surveyor showed the wheelchair's picture to the PT Director who stated that, it was unacceptable and that he would take care of it.
On 2/16/2022 at 10:00 AM, the surveyor interviewed the Certified Nursing Assistant (CNA) who cared for the resident. The CNA stated that Resident #63 was able to assist with care and that he/she was able to use the wheelchair independently. The surveyor observed Resident #63's wheelchair and cushion still in the same condition. The wheelchair was ripped and torn in different parts.
On 2/16/2022 at 11:55 AM, the surveyor interviewed the unit Licensed Practical Nurse (LPN) who stated that staff were supposed to inform maintenance and housekeeping if something was broken or needed cleaning. The LPN had no explanation for why this equipment was not brought to the attention of maintenance and housekeeping.
During a pre-exit conference with the facility administrative staff on 2/23/2022 at 10:40 AM, the Director of Nursing (DON) indicated that the wheelchair cushion was immediately removed and the staff was in -serviced on reporting on any damaged/ broken equipment.
On 2/16/2022 at 9:09 AM, the DON provided the policy titled, Cleaning and Disinfection of Resident- Care Items and Equipment
The policy Statement indicated the following:
Resident-care equipment, including reusable items and durable medical equipment will be cleaned and disinfected according to current CDC recommendations for disinfection and the OSHA Bloodborne Pathogens Standard. The policy did not addressed wheelchair replacement.
NJAC 8: 39 -31.4 ( c)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Assessments
(Tag F0636)
Could have caused harm · This affected 1 resident
Based on interview, record review and review of facility provided documentation, it was determined that the facility failed to complete a Comprehensive admission 14-day Minimum Data Set (MDS) assessme...
Read full inspector narrative →
Based on interview, record review and review of facility provided documentation, it was determined that the facility failed to complete a Comprehensive admission 14-day Minimum Data Set (MDS) assessment or Comprehensive Annual MDS assessment as required according to the Resident Assessment Instrument (RAI) for 5 of 24 residents reviewed for MDS completion (Resident #2, #4, #5, #8 and #363).
The deficient practice was evidenced by the following:
Reference: The Centers For Medicare and Medicaid (CMS) Resident Assessment Instrument (RAI) Version 3.0 Manual classified the Observation (Look Back) Period as the time period over which the resident's condition or status was to be captured by the MDS. The Assessment Reference Date (ARD) referred to the last day of the observation (or look back) period that the assessment covered for the resident. At a minimum, facilities are required to complete a comprehensive assessment for each resident within 14 calendar days after admission to the facility, when there is a significant change in the resident's status and not less than once every 12 months while a resident, where 12 months refers to a period within 366 days.
On 2/15/22, the surveyor reviewed the MDS assessments, an assessment tool used to facilitate the management of care, for the timeliness of submission for 23 system-selected residents.
Information provided by the facility revealed the following for the 5 residents:
1. Resident #2 had an Assessment Reference Date (ARD) of 12/8/21. The assessment was not completed until 2/9/22.
2. Resident #4 had an ARD of 12/29/21. The assessment was not completed until 2/14/22.
3. Resident #5 had an ARD of 12/19/21. The assessment was not completed until 2/14/22.
4. Resident #8 had an ARD of 12/29/21. The assessment was not completed until 2/14/22.
5. Resident #363 had an ARD of 1/20/22. The assessment was not completed until 2/15/22.
On 2/15/22 at 10:31 AM, the surveyor interviewed the MDS Coordinator who stated that there was 14 days to complete the assessment after the ARD. She then confirmed that she had not completed the five MDS. She stated that she was trying to catch up with the assessments when she started in October after the last MDS coordinator left.
On 2/23/22 at 10:09 AM, during surveyor interview, the Director of Nursing (DON) confirmed that the MDS assessments were not done and that they should have been completed in 14 days.
A review of the facility provided policy titled, Resident Assessment Policy and Procedure dated 2020, included the following:
Purpose and Policy. To ensure that .upon a resident's admission and periodically thereafter, conducts a comprehensive, accurate, standardized, reproducible assessment of each resident's functional capacity.
Procedure .
II. Comprehensive assessment/Resident assessment instrument.
A. The Facility shall make a comprehensive assessment of a resident's needs, strengths, goals, life history and preferences, using the resident assessment instrument (RAI) specified by CMS
B. Timeframe for conducting resident assessments. The Facility shall conduct comprehensive assessment of residents:
a. Within 14 calendar days after admission, excluding readmissions in which there is no significant change in the resident's physical or mental condition .
c. Not less often than once every 12 months.
d. The facility may be subject to additional state requirements and timelines.
N.J.A.C. 8:39-11.2
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0638
(Tag F0638)
Could have caused harm · This affected 1 resident
Based on interview, record review and review of facility provided documents, it was determined that the facility failed to complete a Quarterly Minimum Data Set (MDS) assessment, a periodic and federa...
Read full inspector narrative →
Based on interview, record review and review of facility provided documents, it was determined that the facility failed to complete a Quarterly Minimum Data Set (MDS) assessment, a periodic and federally mandated, standardized assessment tool, within the required time frame, according to the Resident Assessment Instrument (RAI) for 15 of 24 residents reviewed for MDS completion (Resident #1, #3, #6, #7, #9, #10, #11, #19, #23, #25, #27, #28, #29, #30 and #50).
The deficient practice was evidenced by the following:
Reference: The Centers For Medicare and Medicaid (CMS) Resident Assessment Instrument (RAI) Version 3.0 Manual classified the Observation (Look Back) Period as the time period over which the resident's condition or status was to be captured by the MDS. The Assessment Reference Date (ARD) referred to the last day of the observation (or look back) period that the assessment covered for the resident. The Quarterly assessment was considered timely if 1). The Assessment Reference Date (ARD) of the Quarterly MDS was within 92 days after the ARD of the previous MDS and; 2). the completion date was no later than 14 days after the ARD.
On 2/15/22, the surveyor reviewed the MDS's, an assessment tool used to facilitate the management of care, for the timeliness of completion for 1 new admission resident and 23 system-selected residents.
Information provided by the facility revealed the following for the 15 residents:
1. Resident #1 had an Assessment Reference Date (ARD) of 12/31/21. The assessment was not completed until 2/14/22.
2. Resident #3 had an ARD of 12/28/21. The assessment was not completed until 2/14/22.
3. Resident #6 had an ARD of 12/19/21. The assessment was not completed until 2/14/22.
4. Resident #7 had an ARD of 12/19/21. The assessment was not completed until 2/14/22.
5. Resident #9 had an ARD of 12/26/21. The assessment was not completed until 2/15/22.
6. Resident #10 had an ARD of 12/24/21. The assessment was not completed until 2/15/22.
7. Resident #11 had an ARD of 12/23/21. The assessment was not completed until 2/14/22.
8. Resident #19 had an ARD of 12/29/21. The assessment was not completed until 2/14/21.
9. Resident #23 had an ARD of 12/28/21. The assessment was not completed until 2/15/22.
10. Resident #25 had an ARD of 1/4/22. The assessment was not completed until 2/15/22.
11. Resident #27 had an ARD of 1/4/22. The assessment was not completed until 2/15/22.
12. Resident #28 had an ARD of 1/4/22. The assessment was not completed until 2/15/22.
13. Resident #29 had an ARD of 1/7/22. The assessment was not completed until 2/16/22.
14. Resident #30 had an ARD of 1/7/22. The assessment was not completed until 2/15/22.
15. Resident #50 had an ARD of 1/9/22. The assessment was not completed until 2/15/22.
On 2/15/22 at 10:31 AM, the surveyor interviewed the MDS Coordinator who stated that there was 14 days to complete the assessment after the ARD. She then confirmed that she did not complete the MDS. She stated that she was trying to catch up with the assessments when she started in October after the last MDS coordinator left.
On 2/23/22 at 10:09 AM, during surveyor interview, the Director of Nursing confirmed that the MDS assessments were not done and that they should have been completed in 14 days.
A review of the facility provided policy titled, Resident Assessment Policy and Procedure dated 2020, included the following:
Purpose and Policy. To ensure that .upon a resident's admission and periodically thereafter, conducts a comprehensive, accurate, standardized, reproducible assessment of each resident's functional capacity.
Procedure .
III. Quarterly review assessment. The Facility shall assess a resident using the quarterly review instrument specified by the State and approved by CMS not less frequently than once every 3 months.
N.J.A.C. 8:39-11.2
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
ADL Care
(Tag F0677)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, it was determined that the facility failed to provide personal grooming care ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, it was determined that the facility failed to provide personal grooming care to a resident that was dependent on the staff for hygiene for 1 of 23 residents, Resident #63. This deficient practice was evidenced by the following:
On 2/17/22 at 10:19 AM, the surveyor observed Resident #63 in the room, awake and was seated on the bed. The resident did not look at the surveyor or speak when spoken to. The resident's fingernails on both hands were long and extended beyond the fingertips. The surveyor also observed Resident #63 with a long, scattered facial hair.
The surveyor reviewed the admission record that indicated Resident #63 was admitted to the facility on [DATE] with diagnoses that included but not limited to Alzheimer's Disease, Depression and Schizophrenia.
A review of the Quarterly Minimum Data Set, an assessment tool used to facilitate care management dated 11/18/21, indicated a Brief Interview for Mental Status scored at 03, which indicated that the resident had severely impaired cognition. The surveyor reviewed the interdisciplinary progress notes from November 2021 through February 2022 which reflected that there was no documentation for any refusal of hygiene personal care.
On 2/17/22 at 10:21 AM, the surveyor spoke to the Licensed Practical Nurse (LPN) assigned to the resident who stated that Resident #63 was non-compliant with hygienic care. The surveyor interviewed the Certified Nursing Assistant (CNA) who stated that part of her responsibility during the morning rounds, included but was not limited to check resident's facial hair and nails. The LPN and the CNA both agreed that the resident's facial hair and fingernails were long and needed to be shaved and trimmed.
A review of the facility's policy titled, Resident Care revealed that the purpose of the procedure was to ensure that each resident shall be cared for in a manner that promotes and enhances his or her sense of well-being, level of satisfaction with life, feeling of self-worth and self-esteem.
On 2/22/22 at 12:30 PM, the surveyor discussed the above concern to the Administrator, Regional Nurse and Director of Nursing. The DON also agreed that the facial hair and the fingernails of Resident #63 needed to be trimmed. No further information was provided.
NJAC 8:39 - 27.2 (g)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Quality of Care
(Tag F0684)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, it was determined that the facility staff failed to follow the physician ord...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, it was determined that the facility staff failed to follow the physician orders for the administration of Ozempic (an anti-diabetic medication) for the treatment of type 2 diabetes mellitus creating a delay in treatment, and failed to assess the resident for first dose response. This deficient practice was identified for Resident #37, one of 23 residents reviewed and was evidenced by the following:
Resident #37 was admitted to the facility with diagnoses which included unspecified atrial fibrillation, type 2 diabetes mellitus with hyperglycemia (elevated blood sugar), chronic kidney disease and unspecified glaucoma.
The Annual Minimum Data Set (MDS - an assessment tool) dated 02/02/22, revealed that Resident #37 had a Brief Interview for Mental Status (BIMS) score of 07/15 which indicated the resident was moderately cognitively impaired.
During the medication pass observation on 02/14/22 at 9:10 AM, the Registered Nurse (RN) informed the surveyor that she had to administer Ozempic to Resident #37. The RN could not locate the Ozempic pen on the medication cart. The RN went to the medication room, retrieved the Ozempic pen and returned with the sealed box containing the Ozempic pen.
The RN stated that she was not familiar with the medication. The RN enlisted the assistance of the Unit Manager RN, UM/RN and the Consultant Pharmacist (CP), to instruct her how to dial the correct dose on the pen. The RN administered the Ozempic dose as ordered, initialed the Medication Administration Record (MAR), and exited the room. The surveyor asked the RN for Resident #37's blood sugar level, the RN stated that there was no order to monitor Resident #37's blood sugar prior to administering the Ozempic pen.
On 02/14/22 at 10:30 AM, the surveyor interviewed the CP regarding his role at the facility and the process for any new medication. The CP indicated that he did not in-service the staff regarding the Ozempic pen. He went on to state that he reviewed all resident orders monthly and would address any irregularities with the facility.
A review of Resident #37's clinical record revealed the following physician order dated 02/11/22: Ozempic (0.25 mg/ml [milligram / milliliter] or 0.5 mg/dose) Solution Pen-injector 2 mg/1.5 ml Semaglutide (0.25 or 0.5 mg/dose) inject 0.25 mg subcutaneously one time a day for DM [Diabetes Mellitus] for 1 week.
The Ozempic pen was ordered on 02/11/22 and arrived from the pharmacy on 02/12/22. The Ozempic pen was to be administered weekly according to the instructions on the box. The order to administer daily was entered incorrectly into the clinical record. The provider pharmacy did not catch the discrepancy nor alert the Attending Physician.
On 02/13/22, the CP forwarded an e-mail to the Director of Nursing (DON) regarding the discrepancy. The facility failed to act in a timely manner and use all available resources to correct the discrepancy. The Medical Director was not called for guidance when the Attending Physician could not be reached.
On 02/14/22 at 10:49 AM, the RN Nursing Supervisor (RN/NS), who received the telephone order revealed that Resident #37's laboratory results were critical and that she reached out to the physician. The physician next gave her the verbal order for Ozempic. The RN/NS further stated that she read the order back to the attending physician to verify. She entered the order into the electronic clinical record where the pharmacy provider obtained, reviewed and sent the Ozempic to the facility.
A review of the February 2022 MAR revealed that the order was entered to be given daily for 7 days. It was also noted that two nurses signed the MAR indicating that Ozempic 0.25 mg was administered to Resident #37 on 02/12/22 and 02/13/22.
On 02/16/22 at 11:28 AM, the surveyor called the pharmacist and was informed that the pharmacy technician who took the order was not available. The surveyor spoke with the pharmacist supervisor who stated that the order should be 0.25 mg once a week. She further stated that the order was checked incorrectly and the pharmacist should have called to clarify the order and notify the facility. Upon further inquiries, she indicated that the order was not double checked. She went on to state that only Intravenous and controlled drugs are double checked. She stated that the resident should be monitored for side effects such as nausea, dizziness diarrhea, and low blood sugar.
The surveyor further asked the pharmacist how many Ozempic pens were delivered. The pharmacist stated only one Ozempic pen was sent to the facility on [DATE]. The surveyor asked if Ozempic was ever ordered daily, the pharmacist replied, No. It is ordered weekly. The pharmacist supervisor indicated that she would investigate further as the pharmacist should have caught the discrepancy and alerted the physician.
On 02/16/22 at 12:06 PM, the surveyor interviewed RN #1 who confirmed that one pen was retrieved from the medication room and the box was sealed. RN #1 indicated that once opened, the pen could be stored in the medication cart. RN #1 further stated that she should have read the information on the box as it clearly indicated to administer the Ozempic weekly.
A telephone interview was conducted on 02/16/22 at 12:20 PM with RN #2. RN #2 stated she had worked on 02/12/22 and could not remember if the medication was available and that she signed the MAR in error. RN #2 stated she did not remember if she had documented it because she had 30 patients that day. RN #2 did not make any late entry documentations.
A telephone interview was conducted on 02/16/22 at 12:40 PM with RN #3. RN #3 had signed for the Ozempic administration on 02/13/22 and stated that she did not administer the medication that day. RN #3 further stated she had signed for the Ozempic but did not administer it. She stated the medication was in the refrigerator and was to be given weekly but that she did not clarify the order nor call the doctor because it was a hectic night. RN #3 stated she did not enter a note in the clinical record to indicate that the Ozempic medication needed to be clarified, nor did she address the issue with the nursing supervisor on duty or the DON.
The Ozempic medication was ordered to be given on 02/12/22. Although the medication was available, the staff failed to administer the Ozempic dose to Resident #37 as ordered by the physician. The facility did not clarify the order with the provider pharmacist. The physician was not made aware that Resident #37 did not receive the Ozempic dose as ordered until 02/14/22.
An interview with the Medical Director on 02/16/22 at 10:55 AM, confirmed that the facility did not call to clarify the Ozempic order until 02/15/22. The DON had received the e-mail on 02/13/22. The DON stated that she could not reach the attending physician. However, the DON did not call the Medical Director for guidance. The Medical Director informed the survey team that he was available 24 hours a day, 7 days a week. He further added, The facility knew how to reach me with any concerns.
On 02/16/22 at 12:17 PM, the DON stated that when she would receive the CP recommendation report, she would review it with the supervisors and call the physician with the recommendations. The DON stated that sometimes the physician would agree and sometimes the physician would not. The DON indicated that she attempted to call the attending physician regarding the Ozempic medication, but the physician could not be reached. The DON acknowledged she did not call the Medical Director for guidance.
On 02/23/22 at 10:30 AM, the DON acknowledged that there was a delay in treatment. The Administrator added that the pharmacist should have picked up the discrepancy and clarified the order with the physician.
Although Resident #37 received the Ozempic first dose on 02/14/22, there was no measures in place to monitor for any responses or side effects associated with the medication. The RN/NS who transcribed the verbal order revealed that the Attending Physician did not inform her of any side effects to monitor for.
According to interviews with the nurses, they were not familiar with the medication, they did not consult the nurse educator nor alert the staff on possible side effects that could be associated with the medication. The facility did not ask the physician about any glucose monitoring.
NJAC 8:39-27.1(a)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Respiratory Care
(Tag F0695)
Could have caused harm · This affected 1 resident
Based on observation, interview, record review, and review of other pertinent documents provided by the facility, it was determined that the facility failed to post cautionary signage to indicate that...
Read full inspector narrative →
Based on observation, interview, record review, and review of other pertinent documents provided by the facility, it was determined that the facility failed to post cautionary signage to indicate that oxygen therapy was in use and to administer oxygen therapy according to the physician's order. This deficient practice was identified for one of two residents reviewed for respiratory care (Resident #24), and was evidenced by the following:
Resident #24 was admitted to the facility with diagnoses which included Chronic Obstructive Pulmonary Disease (COPD), acute kidney failure, diabetes mellitus, and mild intermittent asthma.
A review of the most recent Quarterly Minimum Data Set (MDS - an assessment tool) dated 01/08/2022, revealed that Resident #24 was coded as being dependent on staff for some activities of daily living and was coded as having received Oxygen care. Resident #24 was coded a 12 on the Brief Interview for Mental Status which indicated intact cognition.
During the initial tour on 2/11/2022 at 12:04 PM, the surveyor observed Resident #24 in bed, with oxygen running via (by way of) a nasal cannula (tubing placed in nose for the delivery of oxygen). The oxygen was connected to a concentrator (device used for oxygen delivery). The setting on the concentrator was set to deliver oxygen at 3 liters via nasal cannula. The connected tubing was not labeled or dated. There was no signage at the entrance door to indicate that oxygen therapy was in use.
On 2/11/2022 at 12:40 PM, during a brief review of Resident #24's clinical record, the surveyor noted that the order was for Resident #24 to receive oxygen therapy at 2 liter/per minutes.
On 2/14/2022 at 8:15 AM, the surveyor observed Resident #24 in bed. The oxygen concentrator was turned off. The nasal cannula was noted to be directly on the chair not in any protective covering.
On 2/15/22 at 10:01 AM, the surveyor observed Resident #24 in bed. The oxygen concentrator was turned off. The nasal cannula was noted on the chair on top of the resident's clothing and not in any protective covering.
On 2/16/2022 at 10:04 AM, the surveyor observed the nasal cannula lying direct contact with the floor. Resident #24 was not in the room. The oxygen concentrator was on and titrated at 2.5 liters via nasal cannula. The tubing was labeled and dated 2/14/2022. There was no bag attached to the oxygen concentrator for the storage of the nasal cannula when not in use. There was no signage at the entrance door to indicate that oxygen therapy was in use.
A review of Resident #24's clinical record revealed the following physician orders
Oxygen inhalation (via nasal cannula at 2 Liters/ minute) every shift, check every shift. Start date 10/30/2021.
A second order indicated the following: Oxygen Equipment -Change tubing every days, every night shift, every Sunday. Start date 10/31/2021.
A review of Resident #24's comprehensive care plan dated 7/01/2021 revealed the following focus: I have Asthma/ COPD. The goal was for Resident #24 to be free of respiratory infections. The intervention was as follow: Check Oxygen saturation every shift as ordered. Avoid extreme of hot and cold. Give aerosol or bronchodilators as ordered.
On 2/16/2022 at 10:05 AM, the surveyor interviewed the Licensed Practical Nurse (LPN) regarding the physician order for the oxygen. The LPN confirmed that the order was for oxygen therapy to be delivered at 2 liters per minute. The surveyor escorted the LPN to the room where we both observed the oxygen concentrator titrated at 2.5 liters and the nasal cannula was noted lying in direct contact with the floor and there was no oxygen in use signage posted at the entrance door. The LPN told the surveyor that the 11:00 PM-7:00 PM shift was responsible to change the tubing and ensure that the nasal cannula was protected. The LPN exited the room and left the nasal cannula lying in direct contact with the floor. The LPN did not adjust the oxygen flow to reflect the physician's order.
That same day at 10:30 AM, the surveyor escorted the Assistant Director of Nursing (ADON) to Resident #24's room where we both observed the nasal cannula still lying in direct contact with the floor and no bag attached to the oxygen concentrator to protect/store the nasal cannula when not in use.
The ADON removed the oxygen tubing from the floor, turned off the concentrator, exited the room and told the surveyor that she would replace the setting.
On 2/16/2022 at 10:37 AM, the surveyor observed the ADON and the Unit Manager Registered Nurse, (UM/RN) enter Resident #24's room with a new concentrator, new tubing and a plastic bag to store the tubing when not in use.
A review of the Treatment Administration Record (TAR) on 0/21/2022 at 11:20 AM, revealed that the nurses had signed that the Oxygen therapy had been delivered at 2 liters even on the days the surveyor observed that the oxygen settings were at 3 liters (2/11/2022 ) and at 2.5 liters (2/16/2022).
On 2/17/2022 at 8:34 AM, the DON provided a policy titled, Oxygen Administration. The undated facility's policy indicated that Oxygen will be administered as per MD [Medical Doctor] order to aid in breathing. Emergency oxygen may be administered by licensed nurse without an MD order. The MD will be consulted as soon as possible and order oxygen if continuation is required. This policy confirmed that it was the procedure of the facility to place a No Smoking sign on the resident's door, to check Resident every 2 hours and as needed including source and change as necessary. Lastly to date and initial tubing and humidifiers when started each week.
Procedure
Check MD order
Wash hands Assemble Equipment.
Attach No smoking sign to wall outside the door.
Add nasal cannula or mask with tubing to oxygen source.
Check for flow and apply to resident.
The DON also provided another undated form titled,Respiratory Therapy Prevention of infectionswhich revealed under procedure steps 7 and 8 the following:
7. Change the oxygen cannula and tubing every (7) days, or as needed
8. Keep the oxygen cannula and tubing used PRN in a plastic bag when not in use.
The procedure was not being followed.
On 2/22/2022 at 12:45 PM, the Director of Nursing (DON) and the Licensed Nursing Home Administrator were informed of these concerns and were asked to provide the team with any follow up and policy for oxygen therapy.
NJAC 8:39-11.2(b); 27.1(a)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0710
(Tag F0710)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review and review of pertinent facility documentation, it was determined that the facility failed to ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review and review of pertinent facility documentation, it was determined that the facility failed to seek clarification of a medication order from the Medical Director (MD) when unable to reach a resident's ordering physician. This deficient practice was identified for Resident #37, one of nine residents reviewed during medication administration observation. The deficient practice was evidenced by the following:
On 02/14/22 at 9:01 AM, the surveyor observed the Registered Nurse (RN) on the 4th floor, administering medications to residents including Resident #37. The RN opened a box with a pen injector of Ozempic (an anti-diabetic medication). The RN reviewed the physician order and was unsure of how to use the delivery system pen injector and asked the Unit Manager for assistance. The RN administered the Ozempic. The box which contained the medication revealed in large print that the medication was a once weekly dose.
Review of the February 2022 Medication Administration Record (MAR) revealed that the Ozempic had been signed off as administered on 02/12/22, 02/13/22, and 02/14/22.
A review of Resident #37's admission Record revealed that he/she was admitted to the facility with diagnoses which included but were not limited to Type 2 Diabetes Mellitus (DM) and chronic kidney disease.
A review of Resident #37's medical record progress notes revealed a telephone order from a physician to the facility on [DATE] for Ozempic 0.25 mg (milligram) or 0.5 mg/dose, Solution Pen-injector 2 mg / 1.5 ml (milliliter) inject 0.5 mg subcutaneously one time a day for DM for 1 week.
On 02/14/22 at 11:49 AM, the Nursing Supervisor (NS) who transcribed the verbal order from the physician, stated the process was to enter the order into the computer and document it in the progress note. The NS stated that if the order was questionable, the pharmacy would call and notify the facility. She went on to state that the pharmacy did not call regarding any discrepancies on the Ozempic and that it was a new medication. The NS stated she was not sure if any monitoring needed to be done. She indicated that she read the order back to the physician for clarification and next plotted the order on the MAR for 7 days. The NS stated that she was not too sure if other nurses were familiar with the medication Ozempic and that there was a drug book that the nurses could consult for protocol regarding new medication.
On 02/14/22 at 12:15 PM, two surveyors attempted to phone the ordering physician and a voicemail message indicated that the mailbox was full, so the surveyors were unable to leave a message for the ordering physician. The surveyors attempted to phone the ordering physician's office with no answer.
During an interview on 02/14/22 at 12:17 PM, the Director of Nursing (DON) stated to two surveyors that the Consultant Pharmacist (CP) sent her a recommendation via email on 02/13/22 regarding the Ozempic being a weekly dose. The DON stated she phoned but was unable to reach the ordering physician, so she called the pharmacy who delivers the medications to the facility. She stated she called the pharmacy this morning and the pharmacy was 'looking into' why the order was not clarified. The DON further stated that if a nurse was not familiar with a medication, the expectation would be for the nurse to 'look it up' and that the RN supervisor who was unfamiliar with the Ozempic should have looked it up. The DON stated that a medication being given for the first time in the facility, should be accompanied by education to the nurses.
A review of the electronic progress note dated 02/14/22 at 12:47 PM, revealed the DON attempted to call the ordering physician again to clarify Ozempic order that was given but was unable to get him.
During an interview on 02/14/22 at 1:40 PM, the DON stated that since she was unable to reach the ordering physician, she called the facility Medical Director (MD) and obtained an order to discontinue the Ozempic, do Accuchecks (blood sugar testing) before and after meals for 3 weeks and if less than 120 mg/dl (milligrams per deciliter), call the MD. The DON stated an incident occurrence report would be completed. The DON acknowledged that she had not tried to reach the MD to clarify the order until the following day when the surveyors brought it to her attention.
During an interview on 02/15/22 at 9:46 AM, the DON stated she had attempted to call the ordering physician again to clarify the Ozempic order that was given but was unable to get him. She further stated that any new medication should have some form of monitoring and documentation and if the staff were unable to reach the ordering physician, they should have called the MD.
During an interview on 02/16/22 at 12:17 PM, the DON acknowledged that she called the ordering physician, but could not reach him and stated she had not called the MD for guidance. The DON stated the consequences of a resident receiving too much of the Ozempic could lead to a low blood sugar. The DON acknowledged the resident's blood sugars have not been monitored since November 2021.
On 02/16/22 at 10:55 AM, the surveyor interviewed the MD who stated he visited the facility weekly or twice weekly and had an answering service so he was available 24 hours a day, 7 days a week. The MD stated the facility staff were aware that he could be reached at any time.
A review of the Physician's Progress Note entered by the MD and dated 02/15/22 at 11:27 AM, included at this point, we will allow permissive hyperglycemia as I (MD) am more concerned about a greater risk of hypoglycemia.
A review of the facility provided, Facility Occurrence Report from the pharmacy, dated 02/14/22, included but was not limited to the error category as incorrect direction and delayed/no clarification.
A review of the facility provided, Attending Physician Qualifications and Conditions, revised 4/13, included but was not limited to Policy Statement: attending physicians having privileges to practice in the facility will meet the minimum qualifications and accept the conditions of practice established in the policy. Interpretation and Implementation: 1.c. designate an alternate physician to care for residents during the primary physician's absence; 5. having practice privileges implies that the physician has agreed in writing to abide by relevant rules and regulations and accepts the Medical Director's authority to oversee physician practice in the facility.
NJAC 8:39-23.1(a)(5)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Pharmacy Services
(Tag F0755)
Could have caused harm · This affected 1 resident
Based on observation, interview, and record review, it was determined that the facility failed to provide appropriate pharmaceutical services, which included ensuring accurate administering of all dru...
Read full inspector narrative →
Based on observation, interview, and record review, it was determined that the facility failed to provide appropriate pharmaceutical services, which included ensuring accurate administering of all drugs, in accordance with professional standards of practice. This deficient practice was identified for 2 of 23 residents reviewed (Resident #76 and #37) and was evidenced by the following:
1.) The surveyor reviewed the medical record for Resident #76.
A review of the Face Sheet (an admission summary) reflected that the resident was admitted to the facility with diagnoses which included Epilepsy, Cerebral Palsy, Quadriplegia and Gastrostomy Status (G-Tube), a tube inserted into the stomach that allows nutrition to be directly administered into the stomach.
A review of the admission Minimum Data Set (MDS), an assessment tool used to facilitate the management of care, dated 1/4/22 reflected that the resident had a Brief Interview for Mental Status (BIMS) score of 0 out of 15, which indicated the resident was severely cognitively impaired.
A review of the resident's individualized, comprehensive care plan reflected that Resident #76 had a Seizure Disorder. Interventions included were to provide seizure medication as ordered by the doctor and to monitor/document the side effects and effectiveness.
A review of the Physician Order Summary Report for Resident #76, indicated a Physician's order with a start date of 11/24/21. The order revealed for the resident to receive Nothing by mouth due to dysphasia (difficulty swallowing), and a Physician's order start date of 11/24/21 for Vimpat (a controlled medication used to treat/prevent seizures) 50 mg tablet give 2 tablets via G-Tube.
A review of the Manufacturer's recommendations for Vimpat reflected that Vimpat should not be crushed.
On 2/22/22 at 12:17 PM, the surveyor interviewed the Licensed Practical Nurse (LPN) who regularly administered medications to Resident #76. The LPN stated to the surveyor that she crushed Resident #76's medications including the Vimpat and administered all the medications through the G-tube. The surveyor inquired to the LPN if she was aware that Vimpat should not be crushed. The LPN replied, no I wasn't aware, I will call the doctor now.
A review of the Certified Consultant Pharmacist Monthly Progress Notes dated 1/22/22 did not indicate any recommendations for Vimpat to be changed to a liquid form, or that the Vimpat should not be crushed.
On 2/22/22/at 3:28 PM, the surveyor conducted a phone interview with Resident #76's Primary Care Physician (PCP) who stated that he was not familiar with the medication Vimpat and had not been aware it could not be crushed. He further stated that the pharmacy provider and consultant should have caught this and should have brought it to my attention. He told the surveyor that the hospital physician had originally ordered it and he just renewed it. The PCP acknowledged that he should have reviewed and become familiar with the medications prior to renewing them.
On 2/22/22 at 3:43 PM, the surveyor conducted a phone interview with the Consultant Pharmacist (CP) who stated she was unaware that Vimpat could not be crushed until now. She further stated that she used the American Society of Consultant Pharmacy Medications not to be crushed list, and Vimpat was not on the list. She further stated that the Pharmacy Provider should have identified this, and then should have notified the facility and the Physician.
On 2/23/22 at 9:47 AM, the surveyor discussed the above observations and concerns with the Licensed Nursing Home Administrator and the DON who stated that the nurses should not be crushing the Vimpat and that she would be providing education to the nurses.
2. A review of Resident #37's admission Summary revealed the resident was admitted to the facility with diagnoses which included Unspecified Atrial Fibrillation, Type 2 diabetes mellitus with hyperglycemia, chronic kidney disease and unspecified glaucoma.
The Annual MDS. with an assessment reference date of 2/02/2022. coded Resident #37 as being moderately cognitively impaired. Resident #37 scored 07 out of 15 on the BIMS.
During the medication pass observation on 2/14/2022 at 9:10 AM, the Registered Nurse (RN) informed the surveyor that she had to administer Ozempic an anti-diabetic medication to Resident #37. The RN could not locate the Ozempic pen on the medication cart. The RN went to the medication room, retrieved the Ozempic pen and returned with a sealed box containing the Ozempic pen.
The RN stated that she was not familiar with the medication. The RN enlisted the assistance of the Unit Manager RN, UM/RN, then the Consultant Pharmacist to dial the correct dose on the pen. The RN administered the Ozempic pen, initialed the Medication Administration Record and exited the room. The surveyor asked the RN for Resident #37's blood sugar level, the RN indicated that there was no order to monitor Resident #37's blood sugar prior to administer the Ozempic Pen.
On 2/14/2022 at 10:30 AM, the surveyor interviewed the Consultant Pharmacist regarding his role at the facility and the process for any new medication. The Consultant Pharmacist indicated that he did not in-service the staff regarding the Ozempic Pen. He went on to state that he reviewed all residents orders monthly and addressed any irregularities with the facility.
A review of Resident #37's clinical record on 2/14/2022, revealed the following order: Ozempic (0.25 mg/or 0.5 mg/dose) [milligram/milliliter] Solution Pen-injector 2 mg/1.5 ml) Semaglutide (0.25 or 0.5 mg/dos) inject 0.25 mg subcutaneously one time a day for DM [Diabetes Mellitus] for 1 Week.
The Ozempic pen arrived from the pharmacy on 2/12/2022 and was to be administered daily for one week with a start date of 2/12/2022. The order was entered incorrectly into the clinical record. The provider pharmacy did not catch the discrepancy nor did they alert the Attending Physician of the discrepancy. The Consultant Pharmacist conducted a chart review on 2/12/2022 and sent the discrepancy regarding the Ozempic Pen order via email to the Director of Nursing on 2/13/2022.
On 2/15/2022 at 11:00 AM, the DON stated that she reached out to the provider's pharmacy and the provider pharmacy agreed that the discrepancy should have been addressed by the pharmacist who filled the order and the Attending Physician should have been notified.
On 2/15/2022 at 11:40 AM, the DON provided a Facility Occurrence Report generated by the provider pharmacy. The following were documented:
Summary of Occurrence
The facility entered the directions wrong as daily.
No clarification was done by RPH [Registered Pharmacist] to inform the facility to change the order from daily to weekly.
The coder coded the order as once daily weekly without entering the stop date. The days supply was entered wrong. Instead of 7 days supply, the coder enter 28 days supply.
Error Category
Delayed/ No Clarification
Incorrect Directions
Plan of Correction
Upon Investigation, the following actions are being taken to improve organizational performance.
Inservice Education.
Other: After coding the order the data entry technician should utilize the Preview SIG tab and review what was entered. The sig entered for this order had been entered as Subcutaneous once daily weekly. These directions are incomplete and confusing since they state to give the injection daily and weekly.
The pharmacist should have caught this error and informed the data entry technician the order was entered incorrectly In addition they should have had the order clarified since Ozempic is a once a week medication, not a daily medication.
Both the coder and the pharmacist to be inserviced regarding this error.
An interview with the provider pharmacy on 2/16/2022 at 11:28 AM, confirmed that the Physician order was for Ozempic .25 milligram (mg ) to be administered daily for one week. She went on to state, Absolutely it is overdosed, the order was checked incorrectly. The pharmacist who filled the order should have called the physician and clarified the order.
A review of the facility's provider pharmacy agreement provided by the DON on 2/16/2022 at 9:10 AM, delineated the following responsibilities:
Distribution and related services: For the benefit of residents of the facility, the pharmacy agrees as follows:
Supplies products and services in compliance with all applicable federal, State and local laws, ordinances, rules and regulations (collectively, Law or Laws ) for residents at facility;
Render all services in accordance with any Laws, Joint Commission on the Accreditation of Health Care Organizations standards, as required, and the pharmacy's Policies and Procedures Manual, attached hereto and incorporated herein as Exhibit A;
Label all products in accordance with applicable Laws;
Provide Products and Services in a prompt and timely manner, as specified herein; Provide drug information the facility's license professional staff regarding Products ordered for residents by members of the facility's professional staff;
Provide nurse consulting services, in accordance with applicable Laws, set forth in Exhibit B hereto, including, but not limited to, attending monthly Quality Assurance Committee meetings, consulting on medication administration, and issues related to cost containment.
The provider pharmacy failed to inform the facility of the discrepancy with the Ozempic Pen ordered by the physician. During an interview on 2/16/2022 at 11:35 AM, with the physician who ordered the Ozempic Pen on 2/11//2022, he stated, I was surprised that the provider pharmacy filled the order and sent the medication to the facility. He further stated that the provider pharmacy should have caught the discrepancy .
A review of the Facility's Policy and Procedure entitled, Pharmacy Services-Role of the Consultant Pharmacist indicated:
The Consultant Pharmacist shall provide consultation on all aspects of pharmacy services in the facility and collaborate with the facility and medical director to: Develop, implement, evaluate, and revise (as necessary) the procedures for the provision of all aspects of pharmacy services, including procedures to support resident quality of life such as safe individualized medication administration programs.
NJAC 8:39 - 27.1 (a); 29.3 (a); 29.1 (c);
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0761
(Tag F0761)
Could have caused harm · This affected 1 resident
Based on observation, interview and record review, it was determined that the facility failed to ensure that biological drugs and supplies were removed from the crash cart when expired. This deficient...
Read full inspector narrative →
Based on observation, interview and record review, it was determined that the facility failed to ensure that biological drugs and supplies were removed from the crash cart when expired. This deficient practice was identified on one of two units and was evidenced by the following:
On 02/14/2022 at 10:30 a.m., the surveyor inspected the 400's Unit crash cart with the Unit Manager Registered Nnurse (UM/RN) and noted 3 bottles of normal saline solution with an expiration date of 03/2021. The Ambu bag (a self inflating, hand held device commonly used to provide ventilations to patients who are not breathing ) with a used by date of 04/2021.
An interview with the nurse on 2/14/2021 at 11:30 a.m., revealed that the night supervisor was responsible to check the crash cart. The nurse could not provide any rationale regarding the expired saline solution bottles and the Ambu bag still on the crash cart for use in an emergency.
The facility was made aware of the above issue on 2/21/2022 at 1:15 p.m. On 2/23/2022 at 10:15 a.m.; the Director of Nursing (DON) stated that the expired saline and the Ambu bag were removed from the crash cart. The DON further stated that the 11:00 PM- 07:00 AM supervisor was in- serviced on removing expired drugs and supplies from the crash cart. No policy was provided.
NJAC 8:39-29.4 (g)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Infection Control
(Tag F0880)
Could have caused harm · This affected 1 resident
On 2/14/22 at 8:58 AM, the surveyor observed a staff member walking down a resident hall and back again past the surveyor. The surveyor observed the staff member was wearing a black cloth mask under a...
Read full inspector narrative →
On 2/14/22 at 8:58 AM, the surveyor observed a staff member walking down a resident hall and back again past the surveyor. The surveyor observed the staff member was wearing a black cloth mask under an N95 fitted mask.
During an interview at that time, the staff member was identified as a CNA. The CNA stated she had worked at the facility for 3 years, had been educated on PPE, and had been fit tested for the N95 mask. Donning (applying) and doffing (removing) personal protective equipment (PPE) and washing hands. The CNA further stated she wore the cloth mask under the N95 mask because it was easier to breath that way. The CNA stated she knew she should not have worn the masks like that but was not sure why.
On 2/14/22 at 9:44 AM, the DON stated if a staff member wore two masks, there should not be any mask under a fitted N95 because that would cause the N95 to not be properly fitted at that point.
A review of the facility provided in-service topic Mask N-95 to be worn at all times, staff must properly wear N-95, dated 1/18/22, revealed that the CNA had attended the educational in-service.
A review of the facility provided in-service topic to wear PPE put on and take off, dated 2/1/22, revealed that the CNA had attended the educational in-service.
A review of the CDC N95 PPE, Respirators (https://www.cdc.gov/coronavirus/2019-ncov/hcp/respirator-use-faq.html) included the following:
A respirator is a personal protective device that is worn on the face or head and covers at least the nose and mouth. A respirator is used to reduce the wearer ' s risk of inhaling hazardous airborne particles (including infectious agents), gases or vapors. Respirators, including those intended for use in healthcare settings, are certified by the CDC/NIOSH.
N95 respirators reduce the wearer ' s exposure to airborne particles, from small particle aerosols to large droplets. N95 respirators are tight-fitting respirators that filter out at least 95% of particles in the air, including large and small particles.
Not everyone is able to wear a respirator due to medical conditions that may be made worse when breathing through a respirator. Before using a respirator or getting fit-tested, workers must have a medical evaluation to make sure that they are able to wear a respirator safely.
Achieving an adequate seal to the face is essential. United States regulations require that workers undergo an annual fit test and conduct a user seal check each time the respirator is used. Workers must pass a fit test to confirm a proper seal before using a respirator in the workplace.
When properly fitted and worn, minimal leakage occurs around edges of the respirator when the user inhales. This means almost all of the air is directed through the filter media.
Unlike NIOSH-approved N95s, facemasks are loose-fitting and provide only barrier protection against droplets, including large respiratory particles. No fit testing or seal check is necessary with facemasks. Most facemasks do not effectively filter small particles from the air and do not prevent leakage around the edge of the mask when the user inhales.
The role of facemasks is for patient source control, to prevent contamination of the surrounding area when a person coughs or sneezes. Patients with confirmed or suspected COVID-19 should wear a facemask until they are isolated in a hospital or at home. The patient does not need to wear a facemask while isolated.
NJAC 8:39-19.4(a)(1-2), (b), (k), (n)
Based on observation, interview, record review, and review of pertinent facility documentation, it was determined that the facility failed to 1) store respiratory care equipments in a manner to prevent infections, 2) adhere to infections control practices for hand hygiene according to CDC (Center for Disease Control) and the facility policy, and 3) failed to properly wear an N95 fitted respiratory mask. This deficient practice was identified for three staff members on two units. The deficient practice was evidenced by the following:
1) On 2/11/2022 at 12:04 PM, the surveyor toured the 400's Unit and observed Resident # 24 in bed. The oxygen concentrator (an oxygen delivery system) was set to deliver oxygen therapy at 3 Liters via (by way of) nasal cannula (tubing that is applied to the nose that delivers oxygen). The oxygen tubing and the nasal cannula were not labeled or dated and were observed on top of the concentrator not in any protective covering.
On 2/14/2022 at 8:15 AM, the surveyor observed Resident #24 in bed, the oxygen concentrator was turned off. The nasal cannula was on the chair next to the bed and not in any protective covering.
On 2/15/22 at 10:01 AM, the survery observed that the oxygen concentrator was turned off. The nasal cannula was noted on top of the resident's clothing on the chair next to the bed and not in any protective covering.
On 02/16/22 at 10:04 AM, the surveyor went to the room and observed the oxygen tubing and the nasal cannula in direct contact with the floor. The concentrator was running and the oxygen flow was set to deliver oxygen at 2.5 liter/per minute. There was no bag attached to the concentrator to store the nasal cannula when not in use.
On 02/16/22 at 10:05 AM, the surveyor interviewed the Licensed Practical Nurse (LPN) who administered medications that day. The LPN confirmed that Resident #24 had an physician's order for oxygen to be delivered at 2 liters. The surveyor escorted the LPN to the room where we both observed the flow rate sets to deliver oxygen therapy at 2.5 liters and the oxygen tubing and nasal cannula in direct contact with the floor. Upon further inquiry, the LPN stated that that the night shift was responsible to change the tubing and ensure that the nasal cannula was stored in a plastic bag when not in use. The LPN exited the room and left the oxygen tubing and the nasal cannula lying in direct contact with the floor.
That same day at 10:30 AM the surveyor escorted the Assistant Director of Nursing (ADON) to Resident #24's room where we both observed the nasal cannula still lying in direct contact with the floor. There was no bag attached to the oxygen concentrator to protect/store the nasal cannula when not in use.
The ADON removed the oxygen tubing from the floor, turned off the concentrator, exited the room and told the surveyor that she would replace the setting.
On 2/16/2022 at 10:37 AM, the surveyor observed the ADON and the Unit Manager Registered Nurse (UM/RN) entered Resident #24's room with a new concentrator, new tubing and a plastic bag to store the tubing when not in use.
On 2/17/2022 at 10:30 AM, the ADON provided an in-serviced education folder which addressed care of the oxygen tubing. The following were noted:
The tubing must be dated and changed weekly on Sunday with the date.
When not in use the tube must be stored in a plastic bag.
If the nurse observed the tubing on the floor, the tubing must be thrown away and replaced with a new one.
2. On 02/14/20222 at 08:25 AM, the surveyor informed the Registered Nurse (RN) that she would be observed for medication pass administration.
Prior to the start of the medication pass, the RN entered the room, identified and informed the resident of the procedure. The RN proceeded to the sink and performed hand hygiene. The RN lathered her hands for 07:09 seconds and completed the hand hygiene under running water.
On 2/14/2022 at 9:01 AM, the surveyor observed the RN administer the following medications to Resident # 30 an unsampled resident:
Lioresal 10 mg (milligram )
Neurontin 300 mg
Hydrochlorothiazide 12.5 mg
Lisinopril 5 mg
Paxil 20 mg 1 tablet
Multivitamin 1 tablet.
The RN stated that the medications had to be given with apple sauce. The RN placed the tablets in the medication cup and added the apple sauce.
During the procedure, the RN dropped one of the medications on the medication cart. The RN picked the tablet up with her bare hand and added it to the other medications that were already in the cup. The RN locked the medication cart and proceeded to enter Resident #30's room to administer the medications. The surveyor stopped the procedure and informed the RN that she could not proceed with the medication administration. The RN told the surveyor I should have discarded the tablet and poured another one. The RN went to the medication room, got the drug buster and destroy the above medications.
After the medication pass, the RN again washed her hands for 12.04 seconds.
The surveyor showed the RN the timing on the phone. The RN stated: I singed Happy Birthady too fast.
On 2/14/2022 at 9:10 AM, the surveyor observed the RN preparing Ozempic (an antidiabetic medication pen) for Resident #37. The RN entered the room, informed Resident #37 of the procedure and washed her hands. The RN returned to the medication cart, prepared the Ozempic pen aided by the Consultant Pharmacist, then returned to the bedside to administer the medication. The RN used an alcohol swab to disinfect the site, then proceed to administer the Ozempic pen without donning (putting on) gloves. The surveyor observed that some of the medication was dripping from the site, the RN wiped the site, disposed of the used alcohol pad in the receptacle bin at the bedside and washed her hands for 12.31 seconds.
An interview with the RN regarding the observed practice stated that she should have donned gloves prior to administer the Ozempic for infection control practices. She went on to state that she had received in-services and education on infection control. A review of the RN's file confirmed receipt of in-services and education on Insulin administration.
The facility was made aware of the observed practices on 2/15/2022. On 2/16/2022 at 9:41 AM, the Director of Nursing (DON) provided a policy titled, Handwashing/ Hand Hygiene, dated 01/05/2021. The following were noted:
Policy Statement
The facility considers hand hygiene the primary means to prevent the spread of infections.
Policy Interpretation and implementation
All personnel should be trained and regularly in-serviced on the importance of hand hygiene in preventing the transmission of healthcare-associated infections.
All personnel should follow the handwashing/hand hygiene procedures to help prevent the spread of infections to other personnel, residents, and visitors.
Including in the policy was for staff to Rub hands together using full friction for twenty seconds (20 sec ) ( Not under running water ) singing happy birthday.
A review of the RN's files confirmed that she received in- services education on infections control.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0658
(Tag F0658)
Could have caused harm · This affected multiple residents
On 2/16/22 at 10:20 AM, Surveyor #4 reviewed the Behavior Monitoring Forms for Resident #89 for January 2022 which included the following:
The Behavior Monitoring Form for the psychoactive medication...
Read full inspector narrative →
On 2/16/22 at 10:20 AM, Surveyor #4 reviewed the Behavior Monitoring Forms for Resident #89 for January 2022 which included the following:
The Behavior Monitoring Form for the psychoactive medication Risperdal 3 mg twice a day (BID) had indicated that the behavioral symptoms of delusions were to have been monitored and documented daily on all three shifts. A review of the Behavioral Monitoring Form reflected that the symptom of delusions was only documented for the 7 AM to 3 PM shift and on the 3 PM to 11 PM shift each day for the month of January. The 11 PM to 7 AM shift were blank (not documented) for each day of the month of January.
On 2/17/22 at 11:45 AM, Surveyor #4 reviewed Resident #89's Behavior Monitoring Form for January 2022 again and additional information was added to the forms which included the following:
The Behavior Monitoring Form for Risperdal 3 mg BID had the behavioral symptom of delusions documented for the 11 PM to 7 AM shift for each day of the month of January.
On 2/16/22 at 11:14 AM, Surveyor #4 reviewed Resident #84's Behavior Monitoring Forms for Resident #84 for January 2022 which included the following:
The Behavior Monitoring Form for the psychoactive medication Risperdal had indicated that the behavioral symptoms of sexually preoccupied were to have been monitored and documented daily on all three shifts. A review of the Behavioral Monitoring Form reflected that the symptom of sexually preoccupied was only documented for the 7 AM to 3 PM shift and on the 3 PM to 11 PM shift each day for the month of January. The 11 PM to 7 AM shift were blank (not documented) for each day of the month of January.
On 2/17/22 at 11:46 AM, Surveyor #4 reviewed Resident #84's Behavior Monitoring Form for January 2022 again and additional information was added to the forms which included the following:
The Behavior Monitoring Form for Risperdal had the behavioral symptom of sexually preoccupied documented for the 11 PM to 7 AM shift for each day of the month of January.
On 2/17/22 at 12:53 PM, the DON and LNHA met with the survey team. The DON stated that it should not be happening that one staff member signs behavior monitoring every day whether or not they are present on the unit. The DON stated that documentation goes, forward and that staff should not go backwards to change documentation logs.
On 2/18/22 at 9:05 AM, the DON presented the survey team a statement from the LPN who changed the Behavior Monitoring Forms. The statement indicated that the LPN signed and backdated the January 2022 Behavioral Monitoring Sheets and stated that it was an unwritten common practice to sign the logs for the dates where the nurses can not [be] reached to sign the log as need demands.
On 2/22/22 at 8:30 AM, the DON presented the survey team a statement from the Registered Nurse Supervisor which indicated that, Nurses are reminded to complete and initial the behavior monitoring forms every shift during 11-7 shift.
The facility policy, Behavioral Assessment, Intervention and Monitoring, revised March 2019 indicated that staff will evaluate the resident's mood and behavior, will identify and document the onset, duration, intensity and frequency of behavioral symptoms, and when medications are prescribed for behavioral symptoms, documentation will include monitoring for efficacy and adverse consequences.
A review of the facility provided, Charting and Documentation policy and procedure, revised 7/17, included but was not limited to policy statement: all services provided to the resident, progress toward the care plan goals, or changes in the resident's medical, physical, functional or psychosocial condition, shall be documented in the resident's medical record. The medical record should facilitate communication between the interdisciplinary team regarding the resident's condition and response to care. Interpretation and implementation: 2. the following information is to be documented in the resident medical record: a. objective observations; b. medications administered; c. treatments or services performed; d. changes in the resident's condition; 3. events, incidents or accidents involving the resident; and f. progress toward or changes in the care plan goals and objectives.
NJAC 8:39-11.2 (b), 27.1(a)
5) On 2/16/22 at 10:40 AM, Surveyor #3 reviewed Resident #39's Behavior Monitoring Forms for January 2022 which included the following:
One form for the psychoactive medication Buspar 5 mg had indicated that the behavioral symptoms of hitting and pacing were to have been monitored and documented daily on all three shifts. A review of the form reflected that the symptom of hitting was only documented for the 7 AM to 3 PM shift each day of the month of January. The 3 PM to 11 PM shift and 11 PM to 7 AM shift were blank (not documented) for each day of the month of January. The symptom of pacing was only documented for the 7 AM to 3 PM and 3 PM to 11 PM shift each day of the month of January. The 11 PM to 7 AM shift were blank (not documented) for each day of the month of January.
One form for the psychoactive medication Abilify 2 mg had indicated that the behavioral symptom of hitting was to have been monitored daily on all three shifts. A review of the form reflected that the symptom of hitting was only documented for the 7 AM to 3 PM shift and 3 PM and 11 PM shift each day of the month of January. 11 PM to 7 AM shift were blank (not documented) for each day of the month of January.
On 2/17/22 at 11:40 AM, Surveyor #3 reviewed Resident #39's Behavior Monitoring Forms for January 2022 again and additional information was added to the forms which included the following:
One form for psychoactive medication Buspar 5 mg had the symptoms of hitting and pacing documented for the 11 PM to 7 AM shift for each day of the month of January.
One form for psychoactive medication Abilify 2 mg had the symptom of hitting documented for the 11 PM to 7 AM shift for each day of the month of January.
At 12:22 PM, Surveyor #3 interviewed the fourth floor Unit Manager (UM). The UM confirmed that the 11 PM to 7 AM shift documentation on both of Resident #39's Behavior Monitoring Forms was not on the forms the day before. She added that a staff member must have signed it during the night. The UM also confirmed that the initial listed each day on the 11 PM to 7 AM shift appeared to be the same initial. She then added that only the staff member that is working on that date should sign the form for that date.
6) On 2/14/22 at 8:27 AM, Surveyor #1 observed LPN #1 during the LPN's medication administration pass. LPN #1 was observed to have used her personal blood pressure cuff with a Velcro wrist band, directly on the right wrist of an unsampled resident #1. Surveyor #1 observed that the facility provided portable vitals machine, which included a blood pressure monitor, was in the hall across from LPN #1's medication cart.
7) On 2/14/22 at 8:18 AM, Surveyor #1 was observing LPN #1 during medication administration. LPN #1 had attempted to administer medications to two unsampled residents. The unsampled resident #2 had refused one both medications that were to be administered. LPN #1 returned to the medication cart with the refused medications in a paper pill cup and threw them both into the sharp's container located on the side of the medication cart. At 8:39 AM, the unsampled resident #3 had refused one of four medications to be administered. LPN #1 returned to the medication cart with the refused medication in a paper pill cup and threw it into the sharp's container located on the side of the medication cart.
On 2/14/22 at 9:24 AM, LPN #1 stated the facility provided a medication destroyer but it wasn't around so she just threw the refused medications in the sharp's container. LPN #1 stated her personal wrist blood pressure cuff she was using had been approved by the DON for her to use on residents.
On 2/14/22 at 9:43 AM, the DON stated if a resident refused medications, those pills are to be discarded in the drug buster. The DON stated the medications should not be thrown into the sharp's container because the facility would want to be sure nobody can get to them.
On 2/14/22 at 10:10 AM, the DON stated that the staff were not to use their own personal blood pressure cuffs because a wrist blood pressure cuff was different than an arm blood pressure cuff and there would be no way to document the wrist blood pressure. Also, that there was no way to assure the accuracy of the staff's personal equipment.
A review of the facility provided, Medication Pass Observation, dated 12/1/21 for LPN #1, included but was not limited to PRN, refused and/or partial doses are properly documented and disposed of. The Medication Pass Observation that LPN #1 had been deemed competent / had passed the medication pass observation competency.
A review of the facility provided Inservice with the topic of Medication Pass, dated 1/14/22, included if any medication needs to be wasted must use the drug buster, and was signed by LPN #1.
A review of the facility provided, Blood Pressure, Measuring policy and procedure, updated 10/19, included but was not limited to a stop in the procedure to wrap the blood pressure cuff evenly around the upper arm, approximately one inch from the elbow.
Based on observation, interview, record review, and review of pertinent facility documentation, it was determined that the facility failed to 1) follow acceptable standards of practice for the administration of a controlled medication and 2) failed to maintain accurate accountability and documentation of a controlled medication for 1 of 23 Residents reviewed, Resident # 76, 3) clarifying a physician's medication order for 1 of 9 residents reviewed for medication administration Resident #37; 4) sign for the administration of medication that was not administered for 1 of 9 residents reviewed for medication administration Resident #37, 5) sign for behavior monitoring that was not completed for 3 of 9 residents (Resident #89, #84,and #39) reviewed for behavior logs, 6) use a facility approved blood pressure cuff for 1 of 2 nurses observed for medication administration pass; and 7) use the required method for disposing of unused or refused medications for 1 of 2 nurses observed for medication administration pass. These deficient practices were evidenced by the following:
Reference: New Jersey Statutes, Annotated Title 45, Chapter 11. Nursing Board. The Nurse Practice Act for the state of New Jersey states: The practice of nursing as a registered professional nurse is defined as diagnosing and treating human responses to actual or potential physical and emotional health problems, through such services as case finding, health teaching, health counseling and provision of care supportive to or restorative of life and wellbeing, and executing medical regimes as prescribed by a licensed or otherwise legally authorized physician or dentist.
Reference: New Jersey Statutes, Annotated Title 45, Chapter 11. Nursing Board. The Nurse Practice Act for the state of New Jersey states: The practice of nursing as a licensed practical nurse is defined as performing tasks and responsibilities within the framework of case finding, reinforcing the patient and family teaching program through health teaching, health counseling and provision of supportive and restorative care, under the direction of a registered nurse or licensed or otherwise legally authorized physician or dentist.
This deficient practice was evidenced by the following:
1) The Surveyor #2 reviewed the medical record for Resident #76.
A review of the Face Sheet (an admission summary) reflected that the resident was admitted to the facility with diagnoses which included Epilepsy, Cerebral Palsy, Quadriplegia and Gastrostomy Status (tube inserted into the stomach that allows nutrition to be directly administered into the stomach).
A review of the admission Minimum Data Set (MDS), an assessment tool used to facilitate the management of care, dated 1/4/22 reflected that the resident had a brief interview for mental status (BIMS) score of 00 out of 15, which indicated severely impaired cognition.
A review of the resident's individualized, comprehensive care plan reflected that Resident #76 had a Seizure Disorder with Interventions that included give seizure medication as ordered by doctor. Monitor/document side effects and effectiveness.
A review of the electronic Physician Order Summary Report indicated a Physician's order start date of 11/24/21 for Resident #76 to receive Nothing by mouth due to dysphasia (difficulty swallowing) and a Physician's order start date of 11/24/21 for Vimpat (a controlled medication used to treat/prevent seizures) 50 mg tablet give 2 tablets via G-Tube.
A review of the Manufacturer's recommendations for Vimpat reflected that Vimpat should not be crushed.
On 2/22/22 at 12:17 PM, Surveyor #2 interviewed the Licensed Practical Nurse (LPN)#2 who regularly administered medications to Resident #76. LPN #2 told the surveyor that she crushed Resident #76's medications including the Vimpat and administered all the medications through the G-tube. The surveyor asked LPN #2 if she was aware that Vimpat should not be crushed. LPN #2 replied, no I wasn't aware, I will call the doctor now.
Review of the Certified Consultant Pharmacist Monthly Progress Notes dated 1/22/22 did not document any recommendations related to the Vimpat tablets being crushed.
On 2/22/22/at 3:28 PM, Surveyor #2 conducted a phone interview with Resident #76's Primary Care Physician (PCP) who stated that he was not familiar with the medication Vimpat and wasn't aware it could not be crushed. He further stated that the pharmacy provider and consultant should have caught this and should have brought it to my attention. He told the surveyor that the hospital physician had originally ordered it and he just renewed it. The PCP acknowledged that he should have reviewed the medications prior to renewing them.
On 2/22/22 at 3:43 PM, Surveyor #2 conducted a phone interview with the Consultant Pharmacist (CP) who stated she was unaware that Vimpat could not be crushed because she used the American Society of Consultant Pharmacy Medications not to be crushed list and Vimpat was not on it. She further stated that the Pharmacy Provider should have identified this and should have notified the facility and the Physician.
2.) On 02/23/22 at 9:02 AM, Surveyor #2 observed the LPN exit Resident #76's room and stated she had just administered the liquid Vimpat to Resident #76. The surveyor observed that the LPN had not signed the Individual Patient Controlled Substance Administration Record (IPCSAR) for the dose the LPN had already administered. The LPN stated, I Can't sign before I give it. The LPN further stated that it was her routine practice to sign the IPCSAR and Medication Administration Record (MAR) after she administered the medications.
On 2/23/22 at 9:07 AM, Surveyor #2 interviewed the Registered Nurse/Unit Manager (RN/UM) who stated that she signed the IPCSAR and MAR after the medications were administered.
On 2/23/22 at 9:12 AM, the Nursing Supervisor stated that the IPCSAR should be signed when the medication is removed from the locked box and that the MAR should be signed after the medication was administered.
On 2/23/22 at 9:47 AM, Surveyor #2 discussed the above observations and concerns with the Licensed Nursing Home Administrator (LNHA) and the DON who stated that the IPCSAR should definitely be signed when the medication is removed from the locked box and prior to the administration of the medication. The DON stated she would be providing education to the nurses.
A review of the Controlled Medication Administration Policy Revised April 2007 indicated: The facility shall comply with all laws, regulations, and other requirements related to handling, storage, disposal, and documentation of Schedule II and other controlled substances. No other information was provided by the facility.
3) On 2/14/22 at 9:01 AM, Surveyor #5 observed the Registered Nurse (RN) on the 4th floor administering medications to residents including Resident #37. RN #3 opened a box with a pen injector of Ozempic (a medication used to control high blood sugar) medication. RN #3 reviewed the order, was unsure of how to use the delivery system pen injector and asked the Unit Manager (UM) for help. RN #3 administered the Ozempic. The box which contained the medication revealed that the medication was a once weekly dose.
Review of the Medication Administration Record (MAR) revealed that the Ozempic had been signed off as administered on 2/12/22, 2/13/22, and 2/14/22.
A review of Resident #37's admission Record revealed he/she was admitted to the facility with diagnoses which included but were not limited to Type 2 Diabetes Mellitus and chronic kidney disease.
A review of Resident #37's medical record progress notes revealed a telephone order from a physician to the facility on 2/12/22 for Ozempic 0.25 milligram (mg) or 0.5 MG/DOSE, Solution Pen-injector 2 milligram (MG)/1.5 milliliter (ML) Inject 0.5 mg subcutaneously one time a day for DM for 1 Week.
On 2/14/2022 at 11:49 AM, the Nursing Supervisor (NS) who took the verbal order stated the process was to call the physician, enter the order into the computer and document in the progress note. The NS stated that the pharmacy would obtain the order directly from the electronic medical record where the order was entered. The NS stated that if the order was questionable, the pharmacy would call. She went on to state that the pharmacy did not call regarding the Ozempic, that Ozempic was a new medication, she was not familiar with and was not sure if any monitoring needed to be done. She indicated that she plotted the order on the MAR for 7 days. The NS stated that she was not too sure if other nurses were familiar with the Ozempic and that there was a drug book that the nurses can consult for protocol for new medication.
During an interview on 2/14/22 at 12:17 PM, the DON stated to two surveyors that the consultant pharmacist sent her a recommendation via email on 2/13/22 regarding the Ozempic being weekly. The DON stated she phoned but was unable to reach the ordering physician on 2/13/22. The DON stated she next called the pharmacy who delivers the medications to the facility this morning 2/14/22. The DON further stated that if a nurse was not familiar with a medication, the expectation would be to look it up (the medication) and that the RN supervisor who was unfamiliar with the Ozempic, should have looked up the Ozempic. The DON stated that a medication being given for the first time in the facility, should be accompanied by education to the nurses.
During an interview on 2/14/2022 at 1:40 PM, the DON acknowledged that she had not tried to reach the medical director to clarify the order until the following day when the surveyors brought it to her attention.
An interview with RN #1 revealed that she should have prime the pen to ensure that the correct dose was delivered. She further stated that she should have read the instructions inside the box prior to administer the Ozempic.
Later on during medication reconciliation it was noted that Ozempic was ordered and transcribed incorrectly. The pharmacy consultant indicated on the medication review form that Ozempic should be administered weekly not daily. The form was faxed to the Director of Nursing on 02/13/2022 for follow up.
Further review of the MAR revealed that nurses signed that Ozempic was administered on 02/12 and 02/13/2022.
An interview with the provider pharmacy on 02/16/2022 at 10:28 AM, revealed that one Ozempic pen was delivered at the facility on 02/12/2022. The facility indicated that Ozempic was a new medication and no other resident was ordered Ozempic at the facility.
On 02/16/2022 at 12:20 PM an interview with RN #2 who initialed the MAR on 02/12/2022 indicated that she could not remember if the Ozempic pen was available. She stated that she signed the MAR in error. A review of the electronic progress notes failed to indicate that the nurse assessed Resident #37 for first dose response or indicate that the Ozempic pen was not available.
The surveyor reviewed the electronic progress notes from 02/14/2022 to 02/23/2022 and could not find any late entry in the clinical record regarding the Ozempic order.
An interview with Registered Nurse #3 on 02/16/2022 at 12:40 PM, who signed the MAR on 02/13/2022, indicated that she did not administer the Ozempic pen although she signed the MAR. Nurse #3 stated that she was aware that the medication was available but failed to administer the Ozempic dose because the medication was to be administered weekly.
There was no documented evidence that RN #3 clarified the order with the provider pharmacy or called the physician to clarify the order. She did not discussed the order with the Nursing Supervisor on duty that day nor left a note for the DON to follow up.
On 02/17/2022 at 12:50 PM, the DON was asked to comment on the Ozempic order. The DON indicated that she was aware that the Ozempic medication had not been administered on 02/12/22 and 02/13/22 as reflected on the MAR. She further stated that the physician was notified, the nurses were in-serviced and disciplinary action will follow.
On 02/22/2022 at 10:01 AM, the survey team met with the administrator, the DON, ADON and the Regional Nurse and discussed again the above observations and concerns.
The surveyor requested the facility's policy and procedure for following physician order and for medication administration.
On 02/23/2022 the DON provided a form titled, Administering Medications last revised April 2019, which indicated the following:
Policy heading
Medications are administered in a safe and timely manner, and as prescribed.
Policy interpretation and implementation.
Only persons licensed or permitted by this state to prepare, administer and document the administration medications may do so.
The Director of Nursing Services supervises and directs all personnel who administer medications and/or have related functions.
Medications are administered in accordance with prescriber orders, including any required time frame.
Medications errors are documented, reported, and reviewed by the QAPI committee to inform process changes, and or the need for additional staff training.
If a dosage is believed to be inappropriate or excessive for a resident, or a medication has been identified as having potential adverse consequences for the resident or is suspected of being associated with adverse consequences, the person preparing or administering the medication will contact the prescriber, the resident's Attending Physician, or the Medical Director to discuss the concerns.
The individual administering the medication checks the label three (3 ) times to verify the right resident, right medication, right dosage, right time and right method (route ) of administration before giving the medication.
Each nurses' station has a current Physician's Desk Reference (PDR) and/other medication reference, as well as a copy of the surveyor guidance for 755-761 (Pharmacy Services ) available. Manufacturer's instructions or user's manuals related to any medication administration devices are kept with the devices or at the nurses' station.
The policy was not being followed. The facility did not contact the Medical Director for guidance until the above concern was brought to the DON's attention on 02/15/2022.
4) On 2/15/22 at 9:44 AM, the DON stated that the Medical Director discontinued the Ozempic, ordered blood sugars and monitoring.
On 2/16/22 at 9:29 AM, the ordering physician of the Ozempic for Resident #37 stated the maximum dose of Ozempic would be 1 mg a week and the resident had received three doses of 0.25 mg.
On 2/16/22 at 12:26 PM, Surveyor #5 phoned RN #3 who stated that she signed but did not administer the Ozempic. RN #3 stated that she signed in error because she had 30 residents and just did not document that she did not administer the Ozempic.
On 2/22/22 at 9:14 AM, the DON stated that she had spoken to RN #3 and LPN #4 about administering the Ozempic. The DON stated that both nurses informed her they never administered the medication, had signed that they did, and never documented differently.
On 2/16/22 at 12:45 PM, Surveyor #2 reviewed the Behavior Monitoring Form (BMF) for Resident #44 for January 2022 which included the following:
The Behavior for the psychoactive medication for Depakote 250 mg daily at bedtime had indicated that the behavioral symptoms of disruptive behaviors were to have been monitored and documented daily on all three shifts. A review of the BMF reflected that the symptom of disruptive behavior was only documented for the 7 AM to 3 PM shift and on the 3 PM to 11 PM shift each day for the month of January. The 11 PM to 7 AM shift were blank (not documented) for each day of the month of January.
On 2/17/22 at 11:09 AM, Surveyor #2 reviewed Resident #44's BMF for January 2022 again and the surveyor observed that additional information had been added to the forms which included the following:
The BMF for Depakote 250 mg had the behavioral symptom of disruptive behaviors documented for the 11 PM to 7 AM shift for each day of the month of January.
On 2/17/22 at 11:10 AM, the 4th floor RN/UM stated that the LPN worked last night and that his signature was not there yesterday.
On 2/17/22 at 12:53 PM, the Director of Nursing (DON) and Licensed Nursing Home Administrator (LNHA) met with the survey team. The DON stated that it should not be happening that one staff member signs behavior monitoring every day whether or not they are present on the unit. The DON stated that documentation goes, forward and that staff should not go backwards to change documentation logs.
On 2/18/22 at 9:05 AM, the DON presented the survey team a statement from the LPN who changed the BMFs. The statement indicated that the LPN signed and backdated the January 2022 Behavioral Monitoring Sheets and stated that it was an unwritten common practice to sign the logs for the dates where the nurses cannot [be] reached to sign the log as need demands.
On 2/22/22 at 8:30 AM, the DON presented the survey team a statement from the Registered Nurse Supervisor which indicated that, Nurses are reminded to complete and initial the behavior monitoring forms every shift during 11-7 shift.
The facility policy, Behavioral Assessment, Intervention and Monitoring, revised March 2019 indicated that staff will evaluate the resident's mood and behavior, will identify, and document the onset, duration, intensity ad frequency of behavioral symptoms, and when medications are prescribed for behavioral symptoms, documentation will include monitoring for efficacy and adverse consequences.
The facility policy, Charting and Documentation, revised July 2017 indicated that documentation in the medical record will be objective, complete, and accurate.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Medication Errors
(Tag F0758)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 7. On 2/16/22 at 10:13 AM, surveyor #4 observed Resident#79 lying in bed, awake and alert, calm and soft spoken but with clear s...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 7. On 2/16/22 at 10:13 AM, surveyor #4 observed Resident#79 lying in bed, awake and alert, calm and soft spoken but with clear speech and was able to answer questions appropriately.
A review of the admission Record reflected that the resident was admitted on [DATE] and was readmitted to the facility from the hospital on [DATE].
A review of the 1/6/22, admission MDS indicated a BIMS score of 11, which reflected that the resident's cognition was moderately impaired.
A review of the POS reflected physician orders for Mirtazapine Tablet 15 MG, Give 1 tablet via G-Tube at bedtime for Depression and Escitalopram Oxalate Tablet 10 MG, Give 1 tablet via PEG-Tube one time a day for Depression.
On 2/17/22 at 12:22 PM, the surveyors observed a black binder titled 3RD FLOOR-HIGH SIDE with Behavior Monitoring Form(s) in the binder and Resident #79's form could not be located in the binder. Registered Nurse/Supervisor (RN/S) informed the surveyors that residents' BMF should be in the 3rd floor low side binder. While the RN/S was looking for the binder, she stated we started filling them out last night. RN/S stated that when a resident was on psychotropic medications, the nurses should complete the BMF(s) daily on every shift.
On the same date at 12:28 PM, 3rd floor Licensed Practical Nurse #1 (LPN#1) provided BMF(s) to surveyor #4. The surveyor and LPN#1 could not find BMF for Resident #79. LPN#1 stated that the resident was receiving psychotropic medications and there were supposed to be completed BMFs for the resident. LPN#1 stated, I'm looking for it.
At 1:09 PM, on the same day, the surveyor met again with RN/S and LPN#1 and they both stated that the nurses should complete BMF(s) for the residents who were on psychotic and antianxiety medications. RN/S and LPN#1 also stated that they did not complete BMF(s) for residents who were on antidepressant medications but monitored for side effects by completing Suspected Side Effect Codes forms.
LPN#1 stated the suspected side effects form for Resident#79 was not completed and stated, it was not addressed.
The RN/S informed the surveyor that there were no Suspected Side Effect Codes forms completed for the resident and stated, You won't be able to find one. The RN/S showed an undated BMF for Resident #79 and stated, it's not dated. The form reflected a written Monitor S/E (side effects) and a line across the form. The opposite side of the form titled Suspected Side Effect Codes was blank and not filled out. The RN/S could not provide further information.
LPN#2 informed the surveyor that monthly psych notes for residents on psych medications were generated programmatically, which alerted the nurses to complete psych notes that were due for the residents and stated, computer is programmed, and it will pop in the computer to alert us that it is due for monthly psych notes for the resident.
The 3rd floor RN/UM informed the surveyor that the nurses should document initial psych notes electronically, a month after the resident was admitted to the facility for newly or readmitted residents. She stated, the nurse was supposed to keep tab when the patient came with psych meds and know when to do the initial psych notes. RN/UM also stated that when the initial psych notes was initiated and completed electronically, the computer will automatically alert the nurses for due monthly psych notes documentation thereafter.
The 3rd floor RN/UM stated that the resident was readmitted to the facility on [DATE] with psych medications and the nurses should've been done initial psych notes on 1/30. The 3rd floor RN/UM informed the surveyor that the initial monthly psych notes was missed and there were no initial psych notes completed for Resident #79 after his/her readmission on [DATE]. She also stated that she will remind the nurse to complete monthly psych notes for the resident so it will start rolling. The RN/UM was unable to provide further information.
Surveyor #4 reviewed resident's hybrid medical records reflected there were no monthly behavioral notes for December 2021 and January 2022.
3. On 2/16/2022 at 9:46 AM, surveyor #5 observed Resident #89 in bed in their room.
The surveyor reviewed the medical record for Resident #89.
A review of the admission Record reflected that the resident was admitted to the facility with diagnoses which included but were not limited to anxiety disorder, psychosis, schizoaffective disorder, and schizophrenia.
A review of the quarterly Minimum Data Set (MDS), dated [DATE] reflected that the resident had a brief interview for mental status (BIMS) score of 9 out of 15, which indicated moderately impaired cognition. A further review of the MDS, indicated that the resident exhibited no behavioral symptoms and received antipsychotic medications on 7 out of the last 7 days during the look back period.
A review of the resident's individualized, comprehensive care plan dated 12/24/2020 included a care concern that the resident received antipsychotic medication related to schizophrenia, pervasive developmental disorder, and autism. Interventions included to monitor for the effectiveness of the medication and to monitor for signs and symptoms of adverse reactions to the medication every shift.
A review of the POS indicated an order dated 6/8/2021 for Risperdal (a medication used to treat psychosis) 3 milligrams 1 tablet by mouth two times a day. The Order Summary Report indicated that Risperdal was an active order, and that Resident #89 was still ordered to receive the medication.
On 2/16/2022 at 10:20 AM, the surveyor reviewed the BMF(s) for Resident #89. The review indicated incomplete behavior monitoring in November 2021 with no monitoring occurring on any 7 AM- 3 PM shifts or on any 3 PM- 11 PM shifts. The review failed to indicate any BMF for December 2021. The review indicated an incomplete BMF for January 2022 with no monitoring occurring on any 11 PM to 7 AM shifts. The review failed to indicate any BMF for February 2022.
The BMF for November 2021 listed Resident #89's behavioral symptom as yelling. The BMF for January 2022 listed Resident #89's behavioral symptom as delusions.
The Psychotropic Note Monthly effective on 12/10/21 and inclusive of Resident #89's behaviors for the month of November 2021 listed the resident's targeted behaviors as cursing affecting others and hallucinations. The Psychotropic Note Monthly indicated that the resident had 6 episodes of cursing affecting other and 4 episodes of hallucinations. The BMF for November 2021 indicated that Resident #89 was being monitored for yelling and failed to indicate that the resident was being monitored for either cursing affecting others or hallucinations.
The Psychotropic Note Monthly effective on 1/10/22 and inclusive of Resident #89's behaviors for the month of December 2021 listed the resident's targeted behaviors at cursing affecting others and hallucinations. The Psychotropic Note Monthly indicated that the resident had 6 episodes of cursing and 5 episodes of hallucinations. There was no evidence of a Behavior Monitoring Form for December 2021.
The Psychotropic Note Monthly effective on 2/14/22 and inclusive of Resident #89's behaviors for the month of January 2022 listed the resident's targeted behaviors as cursing affecting others and hallucinations. The Psychotropic Note Monthly indicated that the resident had 0 episodes of either behavior. The Behavior Monitoring Form for January 2021 indicated that Resident #89 was being monitored for delusions and failed to indicate that the resident was being monitored for cursing affecting others or hallucinations.
On 2/16/2022 at 10:35 AM, the surveyor interviewed the RN regarding the February BMF, the RN stated, I don't see any right now and went on to state that there should be a February BMF.
On 2/16/2022 at 11:09 AM, the 4th floor RNUM provided two surveyors with BMF(s) for the past year. A review of these forms failed to indicate BMF(s) for December 2021 or February 2022 on Resident #89 or #84 or on any other resident.
On 2/16/2022 at 11:32 AM, two surveyors interviewed the Assistant Director of Nursing (ADON). The ADON stated that she would expect to see daily monitoring over all three shifts. The ADON further stated that she would expect for the Behavior Monitoring Sheets to lend themselves to the monthly summaries and that the monitored behavioral symptoms would be the same for both.
On 2/17/2022 at 10:39 AM, two surveyors requested all of the past Behavior Monitoring Forms from the RNUM. The RNUM provided the surveyors the monitoring forms. The surveyors asked if this was all of the monitoring that existed for the unit. The RNUM stated, yes.
A review of these BMF revealed a February 2022 BMF for Resident #89 that began on 2/16/2022. The review failed to reveal a BMF for December 2021.
On 2/17/2022 at 12:53 PM, the survey team interviewed the Director of Nursing (DON) and the Licensed Nursing Home Administrator (LNHA). The DON stated that the behaviors monitored on the BMF should match the Psychotropic Note Monthly. The DON stated that it is the responsibility of the night shift nursing supervisor to make sure that the BMF(s) are created monthly.
On 2/18/2022 at 9:35 AM, the survey team again interviewed the DON and LNHA. The DON stated that the behaviors being monitored need to be accurate and that the behaviors logs need to be updated to make sure that each behavior is logged and accounted for. The DON also stated that each shift is responsible to complete the Behavior Monitoring Forms daily.
4. On 2/16/2022 at 10:34 AM, the surveyor observed Resident #84 in a wheelchair in their room.
The surveyor reviewed the medical record for Resident #84.
A review of the admission Record reflected that the reflected that the resident was admitted to the facility with diagnoses which included but were not limited to Alzheimer's Disease, psychosis, and dementia.
A review of the quarterly Minimum Data Set (MDS), an assessment tool used to facilitate the management of care, dated 12/3/2021 reflected that the resident had a brief interview for mental status (BIMS) score of 1 out of 15, which indicated severely impaired cognition. A further review of the MDS, indicated that the resident exhibited no behavioral symptoms and received antipsychotic and antidepressant medications on 7 out of the last 7 days during the look back period.
A review of the resident's individualized, comprehensive care plan dated 10/9/2020 included a care concern that the resident had a psychosocial well-being problem related to depression and schizophrenia and indicated that the resident was taking antidepressant and antipsychotic medications. Another care concern was included indicated that the resident had a problem related to sexually inappropriate behavior. Interventions included to monitor and document Resident #84's behaviors.
A review of the Order Summary Report indicated an order dated 7/18/2021 for a Mirtazapine (a medication used to treat depression) tablet 15 mg given once a day which was active, and an order dated 9/27/2021 for Risperdal (a medication used to treat psychosis) 0.25 mg given at bedtime every Monday, Wednesday, and Friday which was discontinued on 1/19/2021.
On 2/16/2022 at 11:14 AM, the surveyor reviewed the Behavior Monitoring Forms for Resident #84. The review failed to indicate behavior monitoring for November or December 2021 or for February 2022. The review indicated incomplete behavior monitoring for January 2022 with no monitoring completed on the 11 PM- 7AM shift for the month of January.
The Behavior Monitoring Form for January 2022 listed the targeted behavioral symptom as sexually preoccupied.
The Psychotropic Note Monthly effective on 12/13/21 and inclusive of Resident #84's behaviors for the month of November 2021 listed the resident's targeted behaviors as appetite disturbances and delusions disrupting care. The Psychotropic Note Monthly failed to indicate the number of times that the resident exhibited each behavior. There was no evidence of a Behavior Monitoring Form for November 2021.
The Psychotropic Note Monthly effective on 1/13/22 and inclusive of Resident #84's behaviors for the month of December 2021 listed the resident's targeted behaviors as disrobing and as delusions disrupting care.
The Psychotropic Note Monthly indicated that each of these behaviors were not exhibited during the month of December. There was no evidence of a Behavior Monitoring Form for December 2021.
The Psychotropic Note Monthly effective on 2/12/22 and inclusive of Resident #84's behaviors for the month of January 2022 listed the resident's targeted behaviors as appetite disturbances and as helplessness. The Psychotropic Note Monthly failed to indicate the number of times that the resident exhibited each behavior. The Behavior Monitoring Form for January 2022 failed to indicate that the resident was being monitored for either appetite disturbances or helplessness.
8. On 2/11/22 at 9:46 AM, Surveyor #2 observed Resident #39 lying in bed with the sheet covering his/her head. Resident #39 then sat up in the bed but did not respond to Surveyor #2.
The surveyor reviewed the medical record for Resident #39.
A review of the admission Record reflected that the resident was admitted to the facility with diagnoses which included, but were not limited to, dementia without behavioral disturbance, psychosis (an abnormal condition of the mind that results in difficulties determining what is real and what is not real) and hypertension (high blood pressure).
A review of the quarterly MDS, dated [DATE] reflected that the resident had a brief interview for mental status (BIMS) score of 1 out of 15, which indicated severe impaired cognition. A further review of the MDS, indicated that the resident had no behaviors and received psychotropic medications, an antipsychotic medication and an antianxiety medication, on 7 out of the last 7 days during the look back period.
A review of the resident's individualized, comprehensive care plan dated included a care concern that the resident used psychotropic medications (medication affecting the mind or mental processes) with diagnosis of MNC DIS (major neurocognitive disease) with behavioral disturbance. Interventions included, but were not limited to, monitor/record occurrence of for target behavior symptoms (specify: pacing, wandering, disrobing, inappropriate response to verbal communication, violence/aggression towards staff/others, etc.) and document per facility protocol.
A review of the POS of active orders as of 2/17/22, indicated the following psychotropic medication orders: Abilify tablet (medication used for the short-term treatment of agitation that occurs with certain mental/mood disorders) 2 mg give ½ tablet by mouth one time a day for behavioral disturbance; Buspirone tablet (medication used to treat anxiety) 5 mg give 1 tablet by mouth two times a day for anxiety; Depakote tablet (medication used to treat certain psychiatric conditions) delayed release 125 mg give 1 tablet by mouth three times a day for agitation.
A review of Resident #39's November 2021, December 2021, January 2022 and February 2022 electronic Medication Administration Record (eMAR) reflected that the resident received the three psychotropic medications of Abilify, Buspirone and Depakote, each month.
On 2/16/22 at 10:30 AM, in the presence of Surveyor #5, Surveyor #2 asked the Registered Nurse (RN) where the facility documented the behavior monitoring for residents that received psychotropic medications. The RN provided Surveyor #2 a black binder labeled Behavior Monitoring which contained BMFs for the residents on the fourth floor that received psychotropic medications. Surveyor #2 looked in the binder to obtain Resident #39's February 2022 Behavior Monitoring sheet. There was no BMF(s) for February 2022 for Resident #39. There was 3 BMF(s) for January 2022 for Resident #39. Surveyor #2, in the presence of Surveyor #5, asked the RN what the process was for behavior monitoring for residents on psychotropic medications. The RN stated that they use the BMF(s) for any resident on psychotropic medications to monitor target behaviors and for side effects of the medications. She added that the forms for the month were kept in the black binder and that a monthly summary was done in the computer. The RN confirmed that there was not a Behavior Monitoring Form for February 2022 for Resident #39. She added that there should be.
Surveyor #2 then reviewed Resident #39's BMF(s) for January 2022 which included the following information:
One form for the psychoactive (also known as psychotropic) medication Buspar 5 mg had indicated that the behavioral symptoms of hitting and pacing were to have been monitored and documented daily on all three shifts. A review of the form reflected that the symptom of hitting was only documented for the 7 AM to 3 PM shift each day of the month of January. The 3 PM to 11 PM shift and 11 PM to 7 AM shift were blank (not documented) for each day of the month of January. The symptom of pacing was only documented for the 7 AM to 3 PM and 3 PM to 11 PM shift each day of the month of January. The 11 PM to 7 AM shift were blank (not documented) for each day of the month of January. The form indicated that Resident #39 did not have any episodes of hitting or pacing for the month of January 2022.
One form for the psychoactive medication Abilify 2 mg had indicated that the behavioral symptom of hitting was to have been monitored daily on all three shifts. A review of the form reflected that the symptom of hitting was only documented for the 7 AM to 3 PM shift and 3 PM to 11 PM shift each day of the month of January. The 11 PM to 7 AM shift were blank (not documented) for each day of the month of January. The form indicated that Resident #39 did not have any episodes of hitting for the month of January 2022.
One form for the psychoactive medication Depakote 125 mg had indicated that the behavioral symptom of hitting was to have been monitored daily on all three shifts. A review of the form reflected that the symptom of hitting was only documented for the 7 AM to 3 PM shift and 3 PM to 11 PM shift each day of the month of January. The 11 PM to 7 AM shift were blank (not documented) for each day of the month of January. The form indicated that Resident #39 did not have any episodes of hitting for the month of January 2022. There was no evidence that the facility documented Resident #39's behavior monitoring daily on all three shifts for January 2022.
At 10:57 AM, Surveyor #2 reviewed Resident #39's January 2022 Monthly Psychotropic Note dated 2/13/22, which included the following:
1st Psychotropic Medication-Busipirone (Buspar) 5 mg; Target Behavior- Pacing affecting others; Monthly total-9.
2nd Psychotropic Medication- Depakote 125 mg; Target Behavior- Pacing affecting others; Monthly total-left blank.
3rd Psychotropic Medication-Aripiprazole (Abilify) 2 mg; Target Behavior- Pacing affecting others; Monthly total-9.
Resident #39's Monthly Psychotropic Note and the Behavior Monitoring Forms for January 2022 did not contain the same information. The target behaviors that were to be monitored for each medication and the total amount of episodes that occurred during the month were different when the facility summarized the daily Behavior Monitoring Forms into the Monthly Psychotropic Note.
On 2/16/22 at 11:32 AM, in the presence of Surveyor #5, Surveyor #2 interviewed the Assistant Director of Nursing (ADON) regarding the facility process for behavior monitoring for residents on psychotropic medications. The ADON stated that the staff are to document daily on all three shifts on the Behavior Monitoring Form and if they need to describe the behavior additionally, they should write a note in the computer. She then added that the staff would use the daily Behavior Monitoring Forms to document the monthly Psychotropic Note Summary. Surveyor #2 then asked the ADON if the information should be the same on the Behavior Monitoring Form and the monthly Psychotropic Note Summary. The ADON stated that the information should be the same.
At 11:35 AM, Surveyor #2 asked the fourth floor Unit Manager (UM) for Resident #39's November 2021 and December 2021 Behavior Monitoring Forms.
At 11:38 AM, the UM provided Surveyor #2 an additional black binder which contained previous months of Behavioral Monitoring Forms. The binder contained forms from 2021 for the months of January, February, March, June, July and November. Surveyor #2 then asked the UM for Resident #39's December 2021. The UM stated that she would look in her office for the December 2021 forms.
Surveyor #2 then reviewed Resident #39's Behavior Monitoring Forms for November 2021 which included the following information:
One form for the psychoactive medication Buspar 5 mg had indicated that the behavioral symptom of hitting and pacing was to have been monitored daily on all three shifts. A review of the form reflected that the symptoms of hitting and pacing was only documented for the 11 PM to 7 AM shift for November 1 through November 23. The remaining 11 PM to 7 AM shifts from November 24 through November 30 were blank (not documented). The 7 AM to 3 PM and 3 PM to 11 PM shift were blank (not documented) for each day of the month of November. The form indicated that Resident #39 did not have any episodes of hitting or pacing for the November 2021.
One form for the psychoactive medication Abilify 2 mg had indicated that the behavioral symptom of hitting and pacing was to have been monitored daily on all three shifts. A review of the form reflected that the symptoms of hitting was only documented for the 11 PM to 7 AM shift for November 1 through November 28. The remaining 11 PM to 7 AM shifts from November 29 through November 30 were blank (not documented). The symptom of pacing was only documented for the 11 PM to 7 AM shift for November 1 through November 23. The remaining 11 PM to 7 AM shifts from November 24 through November 30 were blank (not documented). The 7 AM to 3 PM and 3 PM to 11 PM shift were blank (not documented) for each day of the month of November. The form indicated that Resident #39 did not have any episodes of hitting or pacing for the November 2021.
One form for the psychoactive medication Depakote 125 mg had indicated that the behavioral symptom of hitting and pacing was to have been monitored daily on all three shifts. A review of the form reflected that the symptoms of hitting and pacing was only documented for the 11 PM to 7 AM shift for November 1 though November 23. The remaining 11 PM to 7 AM shifts from November 24 through November 30 were blank (not documented). The symptom of hitting was documented on the 3 PM to 11 PM on November 1. The remaining 3 PM to 11 PM shifts were blank (not documented). The 7 AM to 3 PM shifts were blank (not documented). The form indicated that Resident #39 did not have any episodes of hitting or pacing for the November 2021. There was no evidence that the facility documented Resident #39's behavior monitoring daily on all three shifts for January 2022.
Surveyor #2 then reviewed Resident #39's November 2021 Monthly Psychotropic Note dated 12/10/21, which included the following:
1st Psychotropic Medication-Busipirone (Buspar) 5 mg; Target Behavior- Pacing affecting others; Monthly total-left blank.
2nd Psychotropic Medication- Depakote 125 mg; Target Behavior- Pacing affecting others; Monthly total-left blank.
3rd Psychotropic Medication-Aripiprazole (Abilify) 2 mg; Target Behavior- Pacing affecting others; Monthly total-left blank.
The Monthly Psychotropic Note and the Behavior Monitoring Forms for November 2021 did not contain the same information. The target behaviors that were to be monitored for each medication were different when the facility summarized the daily Behavior Monitoring Forms into the Monthly Psychotropic Note.
On 2/17/22 at 12:22 PM, Surveyor #2 interviewed the UM. The UM stated that she did not find Resident #39's December 2021 BMF. Surveyor #2 then reviewed Resident #39's December 2021 Monthly Psychotropic Note dated 1/10/22, which included the following:
1st Psychotropic Medication-Busipirone (Buspar) 5 mg; Target Behavior- Pacing affecting others; Monthly total-9.
2nd Psychotropic Medication- Depakote 125 mg; Target Behavior- Pacing affecting others; Monthly total-left blank.
3rd Psychotropic Medication-Aripiprazole (Abilify) 2 mg; Target Behavior- Pacing affecting others; Monthly total-9.
9. On 2/11/22 at 9:41 AM, Surveyor #2 observed Resident #363 lying in bed and was repeating a phrase in Spanish. Resident #363 did not respond to the surveyor.
The surveyor reviewed the medical record for Resident #363.
A review of the admission record reflected that the resident was admitted to the facility with diagnoses which included, but were not limited to, Alzheimer's disease, hypertension (high blood pressure) and persistent mood disorder.
A review of the admission MDS, dated [DATE], reflected that the resident had a BIMS score of 6 out of 15, which indicated severe impaired cognition. A further review of the MDS, indicated that the resident had verbal behavioral symptoms directed toward others daily and other behavioral symptoms not directed toward others daily. The MDS also indicated that the resident received psychotropic medication, an antidepressant, on 7 out of the last 7 days during the look back period.
A review of the resident's individualized, comprehensive care plan included a care concern for the resident that had depression, mood disorder and anxiety and included yelling/screaming at times. Interventions included but were not limited to; allow resident to vent feelings; if resident exhibits any abnormal behavior, allow to calm down and then reapproach; medication reductions as needed.
A review of the POS of active orders indicated the following psychotropic medication orders: Depakote Tablet Delayed release 250 mg give 1 tablet by mouth two times a day for mood disorder; Lexapro tablet (medication used to treat depression and anxiety) 5 mg give 1 tablet by mouth one time a day for depression/general anxiety.
A review of Resident #363's January 2022 and February 2022 electronic Medication Administration Record (eMAR) reflected that the resident received the two psychotropic medications of Depakote and Lexapro each month.
On 2/16/22 at 10:30 AM, in the presence of Surveyor #5, Surveyor #2 asked the Registered Nurse (RN) where the facility documented the behavior monitoring for residents that received psychotropic medications. The RN provided Surveyor #2 a black binder labeled Behavior Monitoring which contained BMF(s) for the residents on the fourth floor that received psychotropic medications. Surveyor #2 looked in the binder to obtain Resident #363's February 2022 Behavior Monitoring Form. There was no BMF for February 2022 for Resident #363. There was no evidence that the facility documented Resident #363's behavior monitoring daily on all three shifts for February 2022. Surveyor #2 then looked in the binder to obtain Resident #363's January 2022 B. There was no BMF for January 2022 for Resident #363. The RN stated that Resident #363 was originally admitted to the third floor unit in January and that Resident #363's January 2022 BMF may still be in that unit's binder.
At 12:23 PM, the third floor Unit Manager provided Surveyor #2 Resident #363's January 2022 Behavior Monitoring Form.
Surveyor #2 then reviewed Resident #363's BMF for January 2022 which included the following information:
One form with no medication listed under Psychoactive Medication had indicated that the behavioral symptoms of yelling and screaming was to have been monitored daily on all three shifts starting 1/14/22 (day after admission). A review of the form reflected that the symptoms of yelling and screaming was only documented for the 7 AM to 3 PM shift on 1/15/22. The remaining 7 AM to 3 PM shifts from January 16 through January 31 were blank (not documented). The 3 PM to 11 PM and 11 PM to 7 AM shift were blank (not documented) for each day of the month of January. There was no evidence that the facility documented Resident #363's behavior monitoring daily on all three shifts for the days the resident resided at the facility during January 2022.
Surveyor #2 then reviewed Resident #363's electronic health record (EHR) for the January 2022 Monthly Psychotropic Note. There was no January 2022 Monthly Psychotropic Note in the EHR.
On 2/17/22 at 12:59 PM, during surveyor interview, the Director of Nursing stated that Resident #363 should have had a Monthly Psychotropic Note done for January 2022. She added that the Monthly Psychotropic Note should be done by the fifteenth of the month.
A review of the facility policy titled, Behavioral Assessment, Intervention and Monitoring with a revised date of March 2019 included the following:
Policy Statement
1. The facility will provide and residents will receive behavioral health services as needed to attain or maintain the highest practicable physical, mental and psychosocial well-being in accordance with the comprehensive assessment and plan of care.
2. Behavioral symptoms will be identified using facility-approved behavioral screening tools and the comprehensive assessment
6. The facility will comply with regulatory requirements related to the use of medications to manage behavioral changes.
Policy Interpretation and Implementation
Management
10. When medications are prescribed for behavioral symptoms, documentation will include: .
e. Specific target behaviors and expected outcomes; .
h. Monitoring for efficacy and adverse consequences .
Monitoring
1. If the resident is being treated for altered behavior or mood, the IDT (interdisciplinary team) will seek and document any improvements or worsening in the individual's behavior, mood and function.
2. The IDT will monitor the progress of individuals with impaired cognition and behavior until stable. New or emergent symptoms will be documented and reported.
A review of the facility provided, Charting and Documentation policy and procedure, revised 7/17, included but was not limited to policy statement: all services provided to the resident, progress toward the care plan goals, or changes in the resident's medical, physical, functional or psychosocial condition, shall be documented in the resident's medical record. The medical record should facilitate communication between the interdisciplinary team regarding the resident's condition and response to care. Interpretation and implementation: 2. the following information is to be documented in the resident medical record: a. objective observations; b. medications administered; c. treatments or services performed; d. changes in the resident's condition; 3. events, incidents or accidents involving the resident; and f. progress toward or changes in the care plan goals and objectives.
A review of the facility policy titled, Tapering Medications and Gradual Drug Dose Reduction with a revised date of April 2007, included the following:
The Attending Physician and staff will identify target symptoms for which a resident is receiving various medications. The staff will monitor for improvement in those target symptoms, and provide the Physician with that information .
The staff and practitioner will monitor side effects closely for antidepressant.
When a medication is tapered or stopped, the staff will closely monitor the resident and will inform the Physician if there is a return or worsening of symptoms.
The facility did not provide the surveyors a policy regarding the Behavioral Monitoring Forms or the Monthly Psychotropic Note.
NJAC[TRUNCATED]